Clincosm LogoSign in Get a demo

Neuroblastoma

Showing 1 - 25 of 393
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

Recruiting
  • Neuroblastoma
  • Ganglioneuroblastoma
  • monoclonal antibodies GD2
  • Moscow, Russian Federation
    Research Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023

Neuroblastoma, High-risk Neuroblastoma, Metastatic Neuroblastoma Trial in United States (OPT-821 (QS-21), oral ß-glucan)

Recruiting
  • Neuroblastoma
  • +2 more
  • OPT-821 (QS-21)
  • oral β-glucan
  • Basking Ridge, New Jersey
  • +6 more
Sep 21, 2023

Neuroblastoma Trial (Naxitamab)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Sep 18, 2023

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Glioma, Childhood Brainstem, Neuroblastoma Trial in San Francisco, Boston (External beam radiotherapy,

Not yet recruiting
  • Glioma, Childhood Brainstem
  • Neuroblastoma
  • External beam radiotherapy
  • 131I-Metaiodobenzylguanidine (MIBG)
  • San Francisco, California
  • +1 more
Aug 17, 2023

Neuroblastoma Trial (GD2 CAR T cells)

Not yet recruiting
  • Neuroblastoma
  • GD2 CAR T cells
  • (no location specified)
Aug 5, 2023

Neuroblastoma Patients

Not yet recruiting
  • Neuroblastoma
    • San Francisco, California
      Power Life Sciences
    Jun 15, 2023

    Brain Tumor, Kidney Tumor, Neuroblastoma Trial in Villejuif (Skin biopsy, Fresh tumor sample, Blood sample)

    Recruiting
    • Brain Tumor
    • +3 more
    • Skin biopsy
    • +4 more
    • Villejuif, France
      Gustave Roussy
    May 26, 2023

    Neuroblastoma Trial in Copenhagen (18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT))

    Recruiting
    • Neuroblastoma
    • 18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT)
    • Copenhagen, Denmark
      Rigshospitalet, Copenhagen University Hospital
    Apr 11, 2023

    Neuroblastoma Trial in Esplugues De Llobregat (Immersive virtual reality imaging, Gold standard imaging)

    Recruiting
    • Neuroblastoma
    • Immersive virtual reality imaging
    • Gold standard imaging
    • Esplugues De Llobregat, Barcelona, Spain
      Hospital Sant Joan de Déu
    Mar 23, 2023

    Neuroblastoma Trial in Moscow, Saint Petersburg (BCD-245)

    Recruiting
    • Neuroblastoma
    • BCD-245
    • Moscow, Russian Federation
    • +2 more
    Mar 13, 2023

    Solid Tumor, Haematological Malignancy, Malignant Tumor Trial in United Kingdom (Alectinib)

    Recruiting
    • Solid Tumor
    • +10 more
    • Belfast, United Kingdom
    • +25 more
    Mar 14, 2023

    Neuroblastoma Trial (horse therapy)

    Not yet recruiting
    • Neuroblastoma
    • horse therapy
    • (no location specified)
    Feb 22, 2023

    Solid Tumors, Neuroblastoma, Rhabdomyosarcoma Trial in Durham, Cincinnati (VAL-413, Temozolomide)

    Recruiting
    • Solid Tumors
    • +5 more
    • Durham, North Carolina
    • +2 more
    Jan 31, 2023

    Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)

    Terminated
    • Neuroblastoma
    • Cancer
    • Biopsy
    • +12 more
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Jan 31, 2023

    Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,

    Recruiting
    • Ganglioneuroblastoma
    • +2 more
    • Computed Tomography
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 30, 2023

    Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Anti-GD2-CAR engineered T cells, AP1903, Cyclophosphamide)

    Completed
    • Sarcoma
    • +3 more
    • Anti-GD2-CAR engineered T cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Neuroblastoma Trial in Australia, Canada, United States (DFMO, Celecoxib, Cyclophosphamide)

    Active, not recruiting
    • Neuroblastoma
    • Los Angeles, California
    • +12 more
    Jan 30, 2023

    Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)

    Active, not recruiting
    • Neuroblastoma
    • Los Angeles, California
    • +11 more
    Jan 30, 2023

    Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

    Recruiting
    • Colorectal Carcinoma
    • +21 more
    • Dual X-ray Absorptiometry
    • +2 more
    • Birmingham, Alabama
    • +18 more
    Jan 30, 2023

    Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)

    Recruiting
    • Neuroblastoma
    • 131I-MIBG
    • +4 more
    • Los Angeles, California
    • +11 more
    Jan 30, 2023

    Neuroblastoma, Solid Tumor Trial (APG-115, APG-2575)

    Not yet recruiting
    • Neuroblastoma
    • Solid Tumor
    • (no location specified)
    Jan 18, 2023

    Endocrine Neoplasms

    Recruiting
    • Endocrine Tumors
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Neuroblastoma Trial in United States (DFMO)

      Active, not recruiting
      Has Results
      • Neuroblastoma
      • Phoenix, Arizona
      • +21 more
      Jan 25, 2023